Skip to main content
OpenTrials

Clinical trial condition

Metabolism, Inborn Errors

Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

2,496 public trials 457 recruiting studies
Refine in advanced search Browse all conditions

Metabolism, Inborn Errors trial results

Completed

Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.

NCT01949467

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diagnosis, Disease, +15 more
Locations
  • CHU Clermont-Ferrand Clermont-Ferrand, France
  • CHU Limoges Limoges, France
  • CHU Montpellier Montpellier, France
  • CHU Pontchaillou Rennes, France
View Trial Details
Completed

Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia

NCT03167697

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +10 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Royal Hospital for Sick Children Edinburgh, United Kingdom
  • Queen Elizabeth University Hospital Glasgow, United Kingdom
  • Guys & St Thomas' Hospital London, United Kingdom
View Trial Details
Completed

Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)

NCT01205152

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +15 more
Locations
  • Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
  • St. John's Medical Research Institute Springfield, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

NCT01907087

Conditions
Batten Disease, CLN2 Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • University Hamburg-Eppendorf Hamburg, Germany
  • Bambino Gesù Children's Hospital Rome, Italy
  • Guy's & St. Thomas NHS Foundation Trust London, United Kingdom
View Trial Details

Related conditions